Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rui Ling
Compound C Enhances the Anticancer Effect of Aspirin in HER-2-positive Breast Cancer by Regulating Lipid Metabolism in an AMPK-independent Pathway
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Next-Generation Sequencing Yields the Complete Chloroplast Genome of Pleione Chunii, a Vulnerable Orchid in China
Mitochondrial DNA Part B: Resources
Genetics
Molecular Biology
Related publications
Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer
PLoS ONE
Multidisciplinary
Androgen-Responsive TRIM36 Enhances Tumor-Suppressive Effect by Regulating Apoptosis-Related Pathway in Prostate Cancer
Cancer Science
Cancer Research
Medicine
Oncology
HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Beclin 1 Acetylation Impairs the Anticancer Effect of Aspirin in Colorectal Cancer Cells
Oncotarget
Oncology
Phloretin Exhibits an Anticancer Effect and Enhances the Anticancer Ability of Cisplatin on Non-Small Cell Lung Cancer Cell Lines by Regulating Expression of Apoptotic Pathways and Matrix Metalloproteinases
International Journal of Oncology
Cancer Research
Oncology
ZEB1 Is Involved in Regulating HER2-positive Breast Cancer Radiosensitivity by Controlling EMT
Oncology Letters
Cancer Research
Oncology
MicroRNA-200c Delivered by Solid Lipid Nanoparticles Enhances the Effect of Paclitaxel on Breast Cancer Stem Cell
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Comparison of the Efficacy and Survival Analysis of Neoadjuvant Chemotherapy for Her-2-Positive Breast Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
